John Q Doyle, President and CEO, on June 02, 2026, sold 16,656 shares in Marsh & Mclennan Companies (MRSH) for $2,693,442. Following the Form 4 filing with the SEC, Doyle has control over a total of 116,811 common shares of the company, with 116,811 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/62709/000006270926000164/xslF345X05/form4.xml
Martine A Rothblatt, Director, Chairperson & CEO, on June 02, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,114,742. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000068/xslF345X05/primarydocument.xml
Karen J Holcom, Senior Vice President & Chief Financial Officer, on June 01, 2026, sold 2,076 shares in Acuity (AYI) for $629,319. Following the Form 4 filing with the SEC, Holcom has control over a total of 19,749 common shares of the company, with 19,447 shares held directly and 302 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1144215/000130226126000006/xslF345X05/wk-form4_1780517855.xml
Elizabeth H Weatherman, Director, on June 03, 2026, executed a purchase for 3,450 shares in Insulet (PODD) for $497,490. Following the Form 4 filing with the SEC, Weatherman has control over a total of 10,352 common shares of the company, with 10,352 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1145197/000114519726000138/xslF345X05/form4.xml